Friday, July 10, 2026

Drug profile · INN

nebivolol

nebivolol (APO-NEBIVOLOL) is a beta-2 adrenergic receptor antagonist. Associated with Alphapharm Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — nebivolol

Quick answer

nebivolol (APO-NEBIVOLOL) is a beta-2 adrenergic receptor antagonist. Associated with Alphapharm Pty Ltd.

Key facts

INN nebivolol
Brand APO-NEBIVOLOL
Mechanism Beta-2 adrenergic receptor antagonist

Mechanism of action

Beta-2 adrenergic receptor antagonist

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. Nebivolol Ophthalmic Suspension 1 Percent Phase 2 · Summit Therapeutics · Open-Angle Glaucoma
  2. APHP180618 Approved · PARItec · Asymptomatic Patients with frequent PVCs and normal LVEF

Frequently asked questions

What is nebivolol?

nebivolol (APO-NEBIVOLOL) is a beta-2 adrenergic receptor antagonist. Associated with Alphapharm Pty Ltd.

What is the brand name for nebivolol?

APO-NEBIVOLOL is a marketed brand name for nebivolol. Check FDA Drugs@FDA for the current US label holder and prescribing information.